IGNE — Igene Biotechnology Income Statement
0.000.00%
Basic MaterialsHighly SpeculativeMicro Cap
Annual income statement for Igene Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2005 December 31st | 2006 December 31st | C2007 December 31st | 2008 December 31st | 2009 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB/A | 10KSB/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 2.29 | 7.64 | 3.96 |
Cost of Revenue | |||||
Gross Profit | — | 0 | 0.605 | 1.25 | 1.02 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.077 | 0.307 | 2.05 | 9.83 | 2.84 |
Operating Profit | -0.077 | -0.307 | 0.238 | -2.19 | 1.12 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.04 | -2.43 | -1.9 | -3.99 | 2.05 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.04 | -2.43 | -1.9 | -3.99 | 2.05 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.04 | -2.43 | -1.9 | -3.99 | 2.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2.04 | -2.43 | -1.9 | -3.99 | 2.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.019 | -0.022 | -0.017 | -0.021 | 0.001 |
Dividends per Share |